MedPath

Temazepam

Generic Name
Temazepam
Brand Names
Restoril
Drug Type
Small Molecule
Chemical Formula
C16H13ClN2O2
CAS Number
846-50-4
Unique Ingredient Identifier
CHB1QD2QSS

Overview

Temazepam, like many other similar and related benzodiazepines, acts as a gamma-aminobutyric acid (GABA) modulator and is capable of eliciting a variety of actions including sedation, hypnosis, skeletal muscle relaxation, anticonvulsant activity, and anxiolytic action . Although the chemical synthesis of temazepam was established by 1965 , mainstream contemporary use of the medication did not occur until it's legitimate use as treatment for insomnia was accepted and approved later on. In particular, before temazepam saw regular prescription use in civilians it was - and still is - employed by the US military as a sedative-hypnotic medication to be taken by soldiers, pilots, etc. to obtain the necessary rest required for medical recovery or scheduled maneuvers and operations . Regardless, temazepam has become one of the most frequently prescribed medications internationally and sees millions of prescriptions every year. Unfortunately, however, given its frequent use and the inherent nature of its pharmacological effects, temazepam - like many other benzodiazepines - possesses a high potential for misuse and is genuinely capable of developing drug tolerance, physical dependence, and addiction in users.

Background

Temazepam, like many other similar and related benzodiazepines, acts as a gamma-aminobutyric acid (GABA) modulator and is capable of eliciting a variety of actions including sedation, hypnosis, skeletal muscle relaxation, anticonvulsant activity, and anxiolytic action . Although the chemical synthesis of temazepam was established by 1965 , mainstream contemporary use of the medication did not occur until it's legitimate use as treatment for insomnia was accepted and approved later on. In particular, before temazepam saw regular prescription use in civilians it was - and still is - employed by the US military as a sedative-hypnotic medication to be taken by soldiers, pilots, etc. to obtain the necessary rest required for medical recovery or scheduled maneuvers and operations . Regardless, temazepam has become one of the most frequently prescribed medications internationally and sees millions of prescriptions every year. Unfortunately, however, given its frequent use and the inherent nature of its pharmacological effects, temazepam - like many other benzodiazepines - possesses a high potential for misuse and is genuinely capable of developing drug tolerance, physical dependence, and addiction in users.

Indication

Temazepam is specifically indicated only for the short-term management of insomnia , . Furthermore, such management is generally predominantly associated with the symptomatic relief of transient and short-term insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings and/or early morning awakenings . In particular, the official prescribing information for temazepam typically specifies that the instructions issued for dispensed prescriptions of the medication should indicate specifically that patients are only expected to use the therapy for short periods of time - usually 7-10 days in general . Subsequently, treatment with temazepam should usually not exceed 7 to 10 consecutive days and nor should it be prescribed in quantities exceeding a one-month supply . Some regional prescribing information also notes that temazepam may be used for premedication prior to minor surgery or other related procedures .

Associated Conditions

  • Insomnia

FDA Approved Products

Temazepam
Manufacturer:Amneal Pharmaceuticals LLC
Route:ORAL
Strength:7.5 mg in 1 1
Approved: 2023/02/13
NDC:65162-583
temazepam
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:30 mg in 1 1
Approved: 2022/01/03
NDC:63629-1057
temazepam
Manufacturer:Proficient Rx LP
Route:ORAL
Strength:15 mg in 1 1
Approved: 2023/06/01
NDC:63187-132
temazepam
Manufacturer:Unit Dose Services
Route:ORAL
Strength:22.5 mg in 1 1
Approved: 2012/06/30
NDC:50436-4630
TEMAZEPAM
Manufacturer:Aphena Pharma Solutions - Tennessee, LLC
Route:ORAL
Strength:15 mg in 1 1
Approved: 2024/03/12
NDC:71610-625

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath